#cannabisaficionado

Industry Innovators

Beard Bros Pharms: Taking Over the Cannabis World One Step at a Time

Published

on

Beard Bros Pharms
Advertisement Back2Grow Advertisement

You could say that Bill and Jeff Levers aka Beard Bros Pharms have created their own cannabis standard. Not only are the brothers master cultivators, consulting for the likes of Kulture and other well-known brands, they are also fierce advocates for social reform, tireless cannabis prisoner campaigners, and savvy businessmen.

Cannabis Aficionado caught up with the Beard Bros to talk about their recent morphing into a full-blown media company, the social impact of legalization, the disruption of Prop 64, and the Small Farms Initiative they’ve been collaborating on with Tim Blake and the Emerald Cup.

CA: Tell me about your journey through entrepreneurship and how you found your way to cannabis?

Beard Bros Pharms: Both of us have been proponents of cannabis from a very young age. We never saw it the way the media portrayed it. Reefer Madness and prohibitionist talking points just never made much sense to either of us. We had always known it was medicinal, non-toxic, and non-lethal. We sometimes feel like we’ve been waiting for the “majority” of society to catch up.

Cultivation of the plant started for us in our teens and has carried through to this day. We have always had an entrepreneurial spirit and the cannabis industry, in general, is all about that. It’s always been a place where people could pursue their dreams and passions, even before it was legal and regulated like it is today. The people who have been in it for decades have had to adapt and improvise to keep up with the changing times as we have, as a community and industry, gone from the shadows to Main Street. To us, this adaptability and drive are some of the very definitions of being an entrepreneur.

What sets Beard Bros Pharms apart from other cultivators?

Initially, it was just our striving to produce the best and cleanest product possible for patients. It was about patients and consumers, not profits. This was no different than any other cultivators out there, but with the commercialization of this plant, it seems we are now among the few, not the many.

What has set us apart since then is our unique perspective and desire to see those less fortunate helped through cannabis and its culture. We’ve managed to stick to our roots and never compromise, even as that has made it harder to compete. We still have a lot of work to do, but we believe in this plant and the culture around it.

Something we realized early on was that this perspective wasn’t necessarily unique, but it wasn’t something people were talking about openly. What started as a way for us to build our product offerings has now morphed into a full-blown media company. A lot of media companies have moved into offering products, but as far as we know we are the only one to do it the other way around: move from products to media.

Beard Bros Pharms

Tell me more about this product-to-press pivot?

Primarily it was the passing of Prop 64 here in California. We realized that Prop 64 made expanding our product offerings much more difficult than it had been previously, so like any good entrepreneur we pivoted.

We also realize that being known for good products in Southern California is certainly a good thing but being known worldwide as a leading source of cannabis news from within the industry is invaluable. We felt we had a good ear to the ground for what was happening in the cannabis world, and really wanted to give a voice to the voiceless by starting the conversations so many wanted to have but were afraid to get started.

So we dove headfirst into telling the story of the culture of cannabis and the people that brought it to fruition as what we see today. Over forty states with medical legislation and nearly twenty with adult-use legislation, each with their own unique challenges, provide us a lot of opportunities to spread our message and thoughts to the world.

Tell us about your product line?

Without getting into too much detail we have scaled our product line down currently. Prior to 2018, we had anywhere from sixty to eighty different products. Starting in 2018 with Prop 64’s over-regulation and over-taxation it has made it extremely difficult and risky to have a product line that is too expansive. So we have gone back to our roots as medical providers. We are currently carrying a high-THC full spectrum cannabis oil and a high-CBD full spectrum cannabis oil that is available throughout California. We also have a full host of low or no THC wellness-based products available nationwide.

We are also currently working on getting a new line of flower products to market under the Beard Bros name as well as under a new name that we aren’t quite ready to announce just yet.

Can you tell me more about the Small Farms Initiative that you’ve been collaborating on with the Emerald Cup?

We are honored to be working once again this year with the team over at the Emerald Cup as so many of our own ideals align with theirs. Among those is the need to support the small, craft cannabis farmers who were immediately and negatively impacted by the passage of Prop 64 here in Cali. These farmers were told that they would have a five-year head start, 2018-2023, before farms larger than one acre would be able to operate. That stipulation was smeared before the ink even dried on the new law and loopholes like license stacking has led to an influx of corporate cannabis operations that can afford to legally grow weed, they just don’t know how and don’t care to learn.

The legacy farmers from places like the infamous Emerald Triangle are quite literally at the root of cannabis culture, which we work every day to preserve and propagate. So, the organic relationship with the Emerald Cup is dear to our hearts at Beard Bros Pharms and we have been loudly promoting their Small Farms Initiative that they launched leading up to the Emerald Cup Harvest Ball in December. The Cup has invited all licensed farms who are under one acre and who use regenerative and responsible standards to apply for one of 27 free booths on the Marketplace floor at the Harvest Ball. These farms will also be promoted by the Cup at the event, along with other benefits that will help raise awareness of these legacy brands.

People look to us as honest purveyors of media and as, let’s just say, “above average” indoor growers from LA. This is another reason why we love the Emerald Cup. Their efforts in recent years, and ahead in 2022, to unify the California cannabis market are admirable and smart. The whole LA vs The Bay or NorCal vs SoCal memes are played out. Anyone in this game who is more worried about promoting their city or zip code instead of their brand and this culture will likely soon have plenty of time to do just that.

What do you see as the social impact of legalization?

That’s an interesting question. We see legalization as a double-edged sword. On one hand, people are not being prosecuted as highly as they were previously. On the other hand, the over-regulation, over-taxation, and the barriers to entry have left so many who have sacrificed so much out of the industry that they helped build. This is an industry built on advocacy and created through activism, and in many ways, it has lost its way.

Just like anything in life, it has its pros and cons. We would like to see the cons minimized as much as possible. We would like to see an industry that allows for the very heart of what we grew up understanding as to the American way: small businesses, craft producers, and the ability for anyone who wants to try to participate to have the ability to do so.

You are advocates of advocating for the freedom of cannabis prisoners. How can people reading this help get behind this movement?

Yes, we are. Let’s just call it like it is… no one should be in prison for weed. Period. At this point, we have been advocates for cannabis prisoners for nearly a decade. We supported it before that but got involved physically about a decade ago.

In our opinion, the best thing people can do is to continue to raise awareness that there are people who are spending tens of years (if not life sentences) for non-violent cannabis charges. It is certainly one of the most egregious errors in our current criminal justice system.

On a more local level find a group that advocates for cannabis prison reform and support them fully. Speak up at every opportunity. Make sure their stories are told. Make sure those still participating in the War on Drugs understand the impacts they are having on lives, families, and more.

What’s the most important thing that needs to be addressed when people are talking about legalization?

First and foremost the main thing to understand is that “legal” can mean different things. “Legal” in Florida is not the same thing in California or Colorado. The distinction isn’t just for consumers and patients either, it is also for businesses.

On the business side, it’s fairly straightforward. What are the barriers to entry? What’s the license structure? Some places, like Oklahoma, are as simple as filling out a form and paying $2500, whereas in others it’s an intense lottery process that can cost tens or hundreds of thousands of dollars just for the ability to try — and potentially fail. Other states fall on a pretty broad scale between these two extremes. Understanding how this impacts businesses, and in turn, consumers is paramount. At Beard Bros, we are against regulatory capture, forced vertical integration, and other protectionist rules that make participating in the market only available for well-funded corporate operations.

On the consumer and patient side the most important issue in our minds is home grow. To us, home growing of cannabis should be a fundamental right included in any legalization method. Home grow allows for those interested to take full control of their cannabis intake. It’s also the key to true entrepreneurship and equality. Home grow allows for experimentation, which leads to innovation, which is the backbone of any successful industry.

Mickey Martin. PHOTO | Beard Bros Pharms

Time to give some props — who do you think deserves respect in the industry?

We’re always going to go back to being inspired by Mickey Martin, an activist and friend of ours that passed a few years ago. The word ‘mentor’ simply means “an experienced or trusted advisor”, and although Mickey certainly served that role for us when we arrived in California, he was so much more than that. A friend, a father, a husband, and without a doubt the most outspoken advocate for cannabis that we have ever met, Mickey was also as business-savvy as they come. We worked with him directly with his Compassion Edibles brand and saw firsthand how he would cut right through the BS that could bog down a good deal. But, in hindsight, our biggest takeaway from our time with Mickey was an appreciation for his razor-sharp truth-telling. When Mickey passed, a massive gap was left in grassroots cannabis journalism and we have been trying our best to honor his legacy and fill that gap ever since.

How do you think the cannabis industry can be better?

That’s a fairly loaded question. There are a ton of problems in our industry. Enough that it could probably be its own article. With that being said we will try to hit a few of the major pieces that we already touched on: Homegrow; lower barriers to entry; legal banking and insurance, and better and more thorough testing

What’s your favorite thing about your job?

Free weed! Ok, so that’s a bit of a joke, but also a very real fringe benefit.

On a more real note, the best part of our job are the messages of support and love from all of our followers, friends, clients, and more. We started cultivating to help people, and we continue to do what we do now for the people.

What do you wish you knew when you started out in cannabis?

Honestly? How hard but also rewarding it was going to be. Both of us have had an entrepreneurial streak for as long as we can remember, but nothing has been as simultaneously challenging and rewarding as the cannabis industry. If we were to go back in time and give ourselves then some advice from us now it would be simple: Focus on the plant and the people. You can’t and won’t ever be able to buy authenticity, but you sure as heck can build it.

What are the three qualities you need to be a successful entrepreneur?

Passion, adaptability, and grit.

Sometimes life in cannabis is hard, and the only thing that will get you through is a true passion for this plant and the community around it. Cannabis is fast-paced, and things change every day, so that’s where adaptability comes in. Grit to us is really a combination of the two, but with a slightly different spin. It’s the internal piece that ensures the first two are always top of mind.

Any advice for anyone that’s thinking about getting into cannabis?

Don’t do it unless you truly care. There are a ton of people here to make money, and it only goes one of two ways: They either sell out entirely, or they fail miserably. This isn’t an industry that many will get rich quick from, and it isn’t an industry where you can just become an overnight success. This is an industry built on the backs of advocates and activists. It’s an industry that has a culture that has been here decades longer than anyone had “weed” on their resume. If you’re not truly passionate about the plant and the people this industry will chew you up and spit you out. It all sort of goes back to the three qualities we listed above.

What’s next for Beard Bros Pharms?

So many things. On the product side of the house, we are going to continue to expand our current offerings throughout California with some exciting deals that we aren’t quite ready to announce yet. We are also working on a new flower brand that should turn some heads once it’s out in the open.

Additionally, we are also in the works of expanding our hemp-derived wellness products from coast to coast. On the media side, we are expanding our original content offerings, growing the team, and focusing heavily on partnerships and events where we are already partnered. Basically… we are setting ourselves up to take over the cannabis world, and doing it one step at a time.

Where can we follow you?

The best and most obvious place is Instagram. @beardbros_pharms is our main page, with a backup at @beardbrospharms just in case the IG police finally catch us. You can also find both of us on LinkedIn under our full names: Bill Levers and Jeff Levers. Signing up for our Friday Sesh Newsletter and checking out our upcoming news show on Social Club TV are also solid ways to keep up with all things Beard Bros Pharms.

Industry Innovators

Auxly’s Cannabis Sales Rise as Last Year’s One-Time Gain Complicates the Profit Comparison

The Canadian cannabis producer’s revenue and operating cash figures improved, while its headline net-income comparison tells a different story.

Published

on

An aisle between warehouse racks filled with cardboard boxes

Auxly’s third-quarter cannabis results offer two headlines that need to be read together. Net revenue increased 24 percent from a year earlier to C$49.5 million, while reported net income declined. The difference does not mean the sales growth disappeared; it reflects, in part, a comparison with a prior-year quarter containing a substantial one-time gain.

The Canadian cannabis producer released its results November 12, 2026 for the three months ended September 30. Its accompanying financial statements and management discussion are dated November 11. Amounts here are Canadian dollars, avoiding a misleading comparison with U.S.-dollar figures reported by other cannabis companies.

Sales growth and the profit comparison

Auxly’s news release reports adjusted EBITDA of C$15.8 million, up 29 percent, and net income of C$13.6 million, compared with C$20.5 million a year earlier. Management notes that the 2025 comparison included a C$8.1 million after-tax gain related to the Imperial debenture settlement.

That creates a reason to examine the components of earnings rather than selecting whichever headline looks most dramatic. A settlement gain can raise reported profit without representing repeatable sales of cannabis. Conversely, removing selected items produces a different measure whose definition and reconciliation still need to be understood.

Adjusted EBITDA is not the same as net income, and neither is simply the amount of cash available for expansion. Auxly identifies adjusted EBITDA as a non-GAAP measure and directs readers to its reconciliation. The useful comparison is between consistently defined measures over time, with the excluded items visible.

The financial statements add a cash distinction

The interim statements report C$14.3 million of net cash provided by operating activities during the quarter. That differs from the C$14.8 million figure before working-capital changes highlighted in the announcement. Both can be accurate because they describe different stages of the cash-flow calculation.

Working capital includes movements in items such as receivables and inventory. A measure calculated before those movements helps isolate one aspect of performance, but it cannot answer every question about cash actually generated during the period. The statements provide the bridge between the two numbers.

At September 30, the statements show C$51.4 million in cash and cash equivalents. That is a balance at a particular date. It should not be confused with the quarter’s revenue, its net income or a promise that the entire balance will be spent on new production.

The statements also label the interim figures unaudited and explain that share and per-share amounts reflect the July 28 share consolidation. Those details matter when comparing old share counts or earnings per share, even though they do not change the basic story about cannabis sales.

Flower and pre-rolls remain central

The management discussion says dried flower and pre-roll products accounted for approximately 64 percent of quarterly net revenue, with the balance from the company’s other cannabis product categories. It attributes year-over-year sales growth to higher volumes across core products and improved flower pricing, partly offset by pressure on vape prices.

That is more informative for readers following the cannabis shelf than an undifferentiated growth percentage. Different formats can move in different directions at the same company. Higher total revenue does not establish that every product category gained pricing power or that every retailer saw the same demand.

The filing also describes the role of Auxly Leamington in cultivation and processing. An integrated production footprint can support supply, but its existence alone does not demonstrate consumer preference, product quality or a future sales result. Those claims require evidence beyond the size of a facility.

The previous quarter supplies context

Auxly’s August 13 second-quarter announcement reported C$45.8 million in net revenue and C$14.3 million in adjusted EBITDA. The third-quarter figures are higher than those earlier results, as well as higher than the year-earlier revenue and adjusted EBITDA comparisons. That is a useful check on the direction of the reported business.

Quarter-to-quarter changes are still different from a sustained trend. Product launches, customer ordering and seasonal patterns can affect individual periods. A single quarter does not establish the eventual return on a capital project or the success of an export strategy.

Our earlier coverage of Weedmaps’ tougher advertising quarter illustrated another part of the cannabis economy. The companies have different business models and reporting measures, so their results should not be treated as interchangeable signals for the whole industry.

For Auxly, the next useful tests are continued demand, cash generation after working-capital movements and the results of planned investments. The present filing supports a specific conclusion: cannabis revenue and several operating indicators improved, while the reported net-income comparison requires attention to last year’s exceptional items.

Illustrative warehouse stock photograph; not an Auxly facility or identified cannabis inventory. Photo: Russ Murray / Unsplash.

Continue Reading

Cannabis

Charlotte’s Web Reports Lower CBD Sales but a Narrower Quarterly Operating Loss

The hemp-derived CBD company’s latest results show why lower revenue and an improving quarterly loss can coexist—and why neither resolves the policy outlook.

Published

on

Empty amber glass bottles arranged on a light surface

Charlotte’s Web reported a difficult sales quarter for its hemp-derived CBD business while narrowing its operating loss. Revenue for the three months ended September 30, 2026 was US$9.4 million, down 18.3 percent from a year earlier. Its operating loss narrowed to US$3.7 million from US$5.3 million, showing why the direction of sales and the direction of a loss do not always match.

The company announced the results November 12 and filed its quarterly report with the U.S. Securities and Exchange Commission. The release attributes weaker revenue primarily to California restrictions that took effect in July, reduced promotional discounting and softer demand in parts of the hemp-wellness market. Those explanations are management’s account of the quarter, rather than an independent measurement of every factor affecting CBD shoppers.

Less revenue does not automatically mean a larger loss

The company’s earnings release reports quarterly gross profit of about US$4.4 million, compared with US$4.5 million a year earlier, even as sales fell. Gross margin improved to 46.9 percent from 38.9 percent. Selling, general and administrative expenses declined to US$8.1 million from US$9.7 million.

A percentage margin and a dollar profit measure answer different questions. A company can retain a larger share of each sales dollar while bringing in fewer dollars overall. Lower expenses can then narrow the operating loss without putting the business into operating profit. That is the distinction these results require.

The announcement also identifies an inventory reserve linked to simplifying the product range. Readers should therefore resist interpreting a single margin percentage as a permanent new baseline. Product mix, pricing, manufacturing costs and inventory adjustments can all affect the calculation.

The quarterly filing keeps the periods straight

The Form 10-Q records quarterly revenue more precisely at US$9.393 million and a net loss of US$3.458 million. These rounded to the US$9.4 million revenue and US$3.5 million net loss in the announcement. An operating loss and a net loss are different lines of the accounts, not conflicting reports of one number.

The nine-month picture is also distinct from the latest quarter. The release reports a US$20.7 million net loss for the first nine months, including noncash items associated with the earlier debenture conversion. It would be misleading to describe an improved third-quarter operating loss as proof that every year-to-date earnings measure improved.

The filing shows US$11.364 million of cash and cash equivalents at September 30. Cash on that date is a financial-position measure, rather than sales or profit earned during the quarter. Looking at the income statement and cash-flow statement together gives a fuller picture than treating a positive cash balance as evidence of profitability.

Hemp policy remains part of the business story

Cannabis policy is directly relevant to this CBD company because the legal definition of hemp determines which products can use that route to market. The Congressional Research Service’s October 28 legal sidebar explains that the federal delay does not move every element of the new definition to the same date. It distinguishes the treatment of certain cannabinoids not naturally produced by the plant from provisions delayed until December 11.

That distinction is useful beyond one company. A hemp-derived label does not settle a product’s future legal status, and a federal deadline does not automatically override a state’s separate rules. Consumers and businesses need to identify the applicable product definition, ingredients and jurisdiction.

Charlotte’s Web’s October 28 announcement said it planned to hold a corporate update after December 11 rather than a November earnings call, seeking greater policy clarity before discussing its outlook. That is a communications plan, not evidence that Congress will produce the outcome the company prefers.

Product access and medical evidence are separate

A financial report from a CBD business does not establish that a product treats a disease or is appropriate for a particular person. Sales trends describe commercial activity. They do not measure a clinical benefit, and a discussion of future healthcare distribution should not be mistaken for a new drug approval or a general reimbursement entitlement.

Our coverage of Willie Nelson’s hemp-policy appeal addresses the public debate over access. Charlotte’s Web’s results supply a different perspective: how a company says restrictions, pricing decisions and expenses are affecting its accounts. The two stories illuminate different parts of the same policy uncertainty.

The next meaningful business signals will include the durability of any sales recovery, spending levels and the details of the legal framework actually in force. For now, the results show a smaller quarterly operating loss alongside lower CBD revenue. They do not yet resolve whether the company can turn that improvement into sustained growth and profitability.

Illustrative empty-bottle stock photograph; not Charlotte’s Web packaging or identified CBD products. Photo: Kelly Sikkema / Unsplash.

Continue Reading

Industry Innovators

Portland Weighs Cannabis Pickup Windows and Licensing Payment Changes

Portland’s cannabis pickup-window and licensing proposal remains under review, with the city record listing a December 8 committee meeting.

Published

on

Portland waterfront buildings seen across the river

Portland is considering removing a city-code restriction on cannabis drive-through and walk-up sales, but the proposal has not become a new retail permission. The city’s record for Ordinance 2026-407 shows the November 10 City Life Committee item was continued, with December 8 listed as its next meeting date.

The proposal introduced by Mayor Keith Wilson combines two subjects: updating the language governing exterior sales windows and revising the way licensing-payment provisions appear in city code. For cannabis shoppers, the first is about how a purchase might be collected. For operators, the second concerns the timing and administration of license costs.

A retailer considering a physical alteration would still need to assess the property and any other applicable approvals. Removing one cannabis-specific sales restriction is not the same thing as approving a building project.

The window restriction is specific

Portland’s current marijuana licensing chapter bars sales from vendor carts, temporary structures, satellite locations and exterior openings such as drive-through facilities or walk-up windows. The proposed amendment would remove the exterior-opening language while retaining restrictions on those other kinds of sales locations.

That is narrower than allowing cannabis sales anywhere a customer can drive or walk. A licensed premises would still be a particular business location, subject to the rest of its applicable requirements. The change concerns a method of serving customers, not the disappearance of the licensing system.

City materials say the amendment would align Portland’s wording with Oregon rules that made on-site delivery a permanent option in September 2020, following temporary pandemic arrangements. That history helps explain why the debate is framed as an update to conflicting language rather than a brand-new statewide retail model.

Convenience does not mean on-site consumption

One important boundary remains in the proposed code exhibit: the provision against consumption on licensed premises is retained, with its existing narrow employee exception under Oregon law. A pickup window and a consumption lounge are different activities.

The same exhibit retains operating-hour and security requirements. Its redline shows a targeted deletion concerning sales openings, rather than an across-the-board removal of the rules governing retail premises. Reading the actual proposed changes is more informative than assuming that the phrase drive-through implies a completely different type of store.

For a customer, the practical questions would still include whether a specific retailer offers a service, how the order is handled and which rules apply. A citywide code amendment, if adopted, would not guarantee that every shop installs a window or changes its property layout.

The payment provisions affect operators differently

The ordinance also addresses the Deferred Payment Program for license fees. The city’s explanation says a 50% initial payment better supports collection and that the code should refer to the council-approved fee schedule rather than preserve outdated dollar amounts.

That is a distinction between the text of the code and the administration of a program. City materials say programmatic changes were communicated in June and July and implementation began in August. The proposal would codify practices already in place, according to the city, rather than introduce every payment change for the first time.

Operators evaluating the proposal therefore need both the amended text and the applicable fee schedule. A headline about pickup windows does not explain a business’s entire licensing bill, and an old fixed amount quoted from code may not describe current program administration.

Businesses are raising questions about cash flow

In KPTV’s November 10 reporting, Mikhala Armstrong described support for greater accessibility alongside concerns from cannabis operators about payment obligations and late fees. Those interviews add an important perspective to the city’s stated goal of improving administration.

The two views are not interchangeable. The city describes its intended program effects; individual operators describe how they believe the arrangements affect their businesses. A final assessment should distinguish those accounts from evidence about what happens after implementation.

Our coverage of Missouri’s interstate cannabis guidance concerned a separate jurisdiction, but illustrates a related point: legal cannabis markets remain governed by specific rules at different levels. A state allowance does not make every local detail irrelevant.

The next step is still a public decision

The city’s document history is the place to follow whether the committee advances or amends the proposal. As of this review, its status is continued, not adopted. Readers should check the updated agenda before relying on the December meeting listing or making plans to offer a new service.

The potential change is concrete: remove a particular restriction on how licensed cannabis stores serve customers and bring fee language into line with current administration. Whether that becomes the final city policy remains the question before Portland, rather than a decision already made.

Illustrative Portland waterfront photograph; not a dispensary or proposed pickup site. Photo: Meggyn Pomerleau / Unsplash.

Continue Reading

Trending

Join The Cannabis Aficionado Community!
Join the Cannabis Aficionado community and receive all of the most relevant news geared towards our sophisticated enthusiast community.
Loading

Copyright ©️ 2026 Cannabis Aficionado. Cannabis Aficionado is a registered trademark of CNM Inc. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Service, Privacy Policy and Cookies Policy. People may receive compensation for some links to products and services. Offers may be subject to change without notice.